Inhibition of phospholipid-facilitated calcium transport by central nervous system-acting drugs.
D000661:Amphetamine / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects*; D001921:Brain / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism*; D002127:Calcium Isotopes; D002247:Carbon Isotopes; D002462:Cell Membrane / Q000187:drug effects; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D007099:Imipramine / Q000494:pharmacology; D008670:Metals / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009269:Nalorphine / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D010743:Phospholipids / Q000502:physiology*
D000700:Analgesics; D002127:Calcium Isotopes; D002247:Carbon Isotopes; D008670:Metals; D009294:Narcotics; D010743:Phospholipids; D002707:Chlordiazepoxide; D009020:Morphine; D000661:Amphetamine; D010424:Pentobarbital; D007099:Imipramine; D002118:Calcium; D002746:Chlorpromazine; D009269:Nalorphine